We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vitrous Analysis in Proliferative Diabetic Retinopathy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01478763
First Posted: November 23, 2011
Last Update Posted: September 25, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Anders Kvanta, St. Erik Eye Hospital
November 21, 2011
November 23, 2011
September 25, 2014
January 2011
September 2014   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01478763 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Vitrous Analysis in Proliferative Diabetic Retinopathy
Analysis of Vitreous Proteins in Patients Undergoing Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy
Analysis of vitreous proteins in patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy
To analyse and compare vitreous proteins in patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy.
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
Vitreous samples
Probability Sample
Patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy
Proliferative Diabetic Retinopathy
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
200
September 2014
September 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • proliferative diabetic retinopathy with vitreous hemorrhage

Exclusion Criteria:

  • vitreous hemorrhage of other cause than proliferative diabetic retinopathy
  • previous vitrectomy
Sexes Eligible for Study: All
12 Years and older   (Child, Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Sweden
 
 
NCT01478763
Vitreous1
No
Not Provided
Not Provided
Anders Kvanta, St. Erik Eye Hospital
Anders Kvanta
Not Provided
Principal Investigator: Anders Kvanta, PhD St. Erik Eye Hospital
St. Erik Eye Hospital
September 2014